Updated May 2026
Ozempic vs Rybelsus
Side-by-side comparison of Ozempic (semaglutide (T2D injection)) and Rybelsus (semaglutide (oral)) across efficacy, food restrictions, monthly cost, and Medicare Bridge coverage.
Our pick for most patients
Rybelsus
Based on the data below, Rybelsus wins on higher peak weight loss (10% vs 8%). Your situation may differ — try the personalized matcher on the homepage or compute your real out-of-pocket with the cost calculator on each medication's detail page.
| Field | Ozempic | Rybelsus |
|---|---|---|
| Route | injection · weekly | tablet · daily |
| Avg weight loss | 5–8% | 8–10% |
| Food restriction | No food restriction | 30-min fast required |
| Cash from | $998/mo | $998/mo |
| Savings card | — | — |
| Medicare Bridge | Tier 4 | Tier 4 |
| A1c reduction | −1.8% | −1.4% |
| FDA approved | 2017-12 | 2019-09 |
- RouteOzempicinjection · weeklyRybelsustablet · daily
- Avg weight lossOzempic5–8%Rybelsus8–10%
- Food restrictionOzempicNo food restrictionRybelsus30-min fast required
- Cash fromOzempic$998/moRybelsus$998/mo
- Savings cardOzempic—Rybelsus—
- Medicare BridgeOzempicTier 4RybelsusTier 4
- A1c reductionOzempic−1.8%Rybelsus−1.4%
- FDA approvedOzempic2017-12Rybelsus2019-09
Pick Ozempic if…
- You can't reliably do a fasting window before meds
Pick Rybelsus if…
- You're needle-averse
- You want the higher peak efficacy (10% vs 8%)
Not sure which fits?
The 30-second matcher on the homepage scores every 2026 GLP-1 against your goals + preferences and recommends the best fit.